Erschienen in:
15.03.2019 | Breast Oncology
Response to: “Intact Excision of Breast Lesions Using BLES™: Is There a Clinical Indication Yet?”
verfasst von:
Pat Whitworth, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 6/2019
Einloggen, um Zugang zu erhalten
Excerpt
In response to our article
1, in her editorial
2 Yao states that a second procedure was needed to achieve clear margins in 27% of patients: “Of 124 cancer patients, 55% had clear margins after undergoing a biopsy with the BLES device, 27% underwent another procedure with the BLES device to establish negative margins”. She repeats this error when summarizing the results in cancer patients: “In the current study, 55% of cancerous lesions (DCIS and invasive carcinoma) had complete excision, with one procedure using the BLES device, and 45% of patients had to undergo another procedure, either with the BLES device or surgical excision”. …